Diseases Covered

Metastatic Castrate Resistant Prostate Cancer

Program Status

closed

Applications or renewals for this condition are currently unavailable. The organizations below may offer funding for this condition.

Copay Assistance Organizations

These sister charities are also dedicated to helping people afford life-changing treatments and medications.

Support Organizations

These organizations do not offer co-pay assistance, but they offer valuable information and support.

Eligibility Criteria

  • Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
  • Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
  • Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
  • Patient must be diagnosed with a covered disease and program must be accepting enrollments.
  • Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.

Medications Covered

  • Abiraterone
  • Abirtega
  • Asmalpred
  • Beizray
  • Docefrez
  • Docetaxel
  • Docivyx
  • Firmagon
  • Jevtana
  • Keytruda
  • Lynparza
  • Medicort
  • Millipred
  • Orapred
  • Orapred ODT
  • Pediapred
  • Pluvicto
  • Prednisolone
  • Provenge
  • Rubraca
  • Talzenna
  • Taxotere
  • Vitrakvi
  • Xofigo
  • Xtandi
  • Yonsa
  • Zytiga

Disease Description

Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. (Source: NIH; National Cancer Institute)